Search Results - "Shojo, Kazunori"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations by Kobayashi, Hiroaki, Kosaka, Takeo, Nakamura, Kohei, Shojo, Kazunori, Hongo, Hiroshi, Mikami, Shuji, Nishihara, Hiroshi, Oya, Mototsugu

    Published in BMC medical genomics (09-10-2021)
    “…Ductal adenocarcinoma and neuroendocrine cancer are rare subtypes of prostate cancer with poor prognosis and limited therapeutic options. We present the first…”
    Get full text
    Journal Article
  5. 5

    First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion by Shojo, Kazunori, Kosaka, Takeo, Nakamura, Kohei, Hongo, Hiroshi, Kobayashi, Hiroaki, Mikami, Shuji, Nishihara, Hiroshi, Oya, Mototsugu

    Published in IJU case reports (01-05-2021)
    “…Introduction Ductal adenocarcinoma of the prostate is a rare prostate cancer variant and associated with higher stage and greater risk of mortality. Optimal…”
    Get full text
    Journal Article
  6. 6

    Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins by Shojo, Kazunori, Tanaka, Nobuyuki, Murakami, Tetsushi, Anno, Tadatsugu, Teranishi, Yu, Takamatsu, Kimiharu, Mikami, Shuji, Imamura, Takeshi, Matsumoto, Kazuhiro, Oya, Mototsugu

    Published in Laboratory investigation (01-10-2024)
    “…Targeting novel inhibitory ligands beyond anti-PD-1 and PD-L1 and CTLA-4 therapies is essential for the next decade of the immunotherapy era. Agents for the B7…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion by Shojo, Kazunori, Kosaka, Takeo, Nakamura, Kohei, Hongo, Hiroshi, Kobayashi, Hiroaki, Mikami, Shuji, Nishihara, Hiroshi, Oya, Mototsugu

    Published in IJU case reports (01-05-2021)
    “…INTRODUCTIONDuctal adenocarcinoma of the prostate is a rare prostate cancer variant and associated with higher stage and greater risk of mortality. Optimal…”
    Get full text
    Report